Dr Phil Bate Orthomolecular Pioneer | Dangers of Ritalin Et Al Page featuring Neuroliminal Training (NT) NT does what EEG Biofeedback does at a low cost! |
NT Solves Most Brain Problems Including: ADD/ADHD/Autism Depression, Anxiety Insomnia, Epilepsy And much more that families can afford |
Discontinuing Any Drugs
It's never a good idea to just stop taking any drug that the body has become adjusted to. This includes Ritalin, Adderall, Concerta, Strattera,and all other similar drugs. One way to do this is to cut the dosage in half for a week, then in half again for another week, and then cut it out. Watch for any withdrawal symptoms (flu type symptoms are most common).
WHAT'S WRONG WITH RITALIN?
But that has little to do with the most obvious reason millions of American children are taking Ritalin, Adderall, Concerta, and Strattera, compliance. One day at a time, the drug continues to make children do what their parents and teachers either will not or cannot get them to do without it: Sit down, shut up, keep still, pay attention. In short, Ritalin is a cure for childhood." -- Mary Eberstadt (Reading, Writing, and Ritalin)
The following articles are only the tip of the iceberg. Using "Ritalin" as a search word turned up over 50,000 references. Most of these cite known dangers. Every parent who has an ADD/ADHD child, and is considering the use of Ritalin, Adderall, Concerta, Strattera, or other drugs, should read all this information FIRST!
- What the US Drug Enforcement Agency Says About Ritalin
- Ritalin may cause permanent brain damage
- The complete transcript of the NBC Dateline program on Ritalin
- Hazards of Treating Attention-Deficit/Hyperactivity Disorder with Methylphenidate (Ritalin)
- The fraud of Child Psychiatry, ADD/ADHD, Attention Deficit Disorder and Ritalin.
- Why to Avoid Ritalin
- Help our Children be FREE of Ritalin!!
- On September 29, 2005, The FDA directed Eli Lilly and Company (Lilly), the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a
boxed warning and additional warning statements that alert health careproviders of an increased risk of suicidal thinking in children and adolescents being treated with this medication.
FDA also informed Lilly that a Patient Medication Guide (MedGuide) should be provided to patients when Strattera is dispensed. The MedGuide advises patients of the risks associated with and precautions that can be taken when Strattera is dispensed. Further, pediatric patients being treated with Strattera should be closely observed for clinical worsening, as well as agitation,irritability, suicidal thinking or behaviors, and unusual changes inbehavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.
sign up for Dr Bate's newsletter.
You'll get a free copy of his book "The Health Revolution"plus useful free health information.
Just enter your email address below. It'll never be passed on to others.
